Literature DB >> 25136083

TIM-family proteins inhibit HIV-1 release.

Minghua Li1, Sherimay D Ablan2, Chunhui Miao1, Yi-Min Zheng1, Matthew S Fuller1, Paul D Rennert3, Wendy Maury4, Marc C Johnson1, Eric O Freed2, Shan-Lu Liu5.   

Abstract

Accumulating evidence indicates that T-cell immunoglobulin (Ig) and mucin domain (TIM) proteins play critical roles in viral infections. Herein, we report that the TIM-family proteins strongly inhibit HIV-1 release, resulting in diminished viral production and replication. Expression of TIM-1 causes HIV-1 Gag and mature viral particles to accumulate on the plasma membrane. Mutation of the phosphatidylserine (PS) binding sites of TIM-1 abolishes its ability to block HIV-1 release. TIM-1, but to a much lesser extent PS-binding deficient mutants, induces PS flipping onto the cell surface; TIM-1 is also found to be incorporated into HIV-1 virions. Importantly, TIM-1 inhibits HIV-1 replication in CD4-positive Jurkat cells, despite its capability of up-regulating CD4 and promoting HIV-1 entry. In addition to TIM-1, TIM-3 and TIM-4 also block the release of HIV-1, as well as that of murine leukemia virus (MLV) and Ebola virus (EBOV); knockdown of TIM-3 in differentiated monocyte-derived macrophages (MDMs) enhances HIV-1 production. The inhibitory effects of TIM-family proteins on virus release are extended to other PS receptors, such as Axl and RAGE. Overall, our study uncovers a novel ability of TIM-family proteins to block the release of HIV-1 and other viruses by interaction with virion- and cell-associated PS. Our work provides new insights into a virus-cell interaction that is mediated by TIMs and PS receptors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25136083      PMCID: PMC4156686          DOI: 10.1073/pnas.1404851111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  TIM-1 induces T cell activation and inhibits the development of peripheral tolerance.

Authors:  Sarah E Umetsu; Wan-Ling Lee; Jennifer J McIntire; Laura Downey; Bharati Sanjanwala; Omid Akbari; Gerald J Berry; Haruo Nagumo; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

2.  Human TIM-1 associates with the TCR complex and up-regulates T cell activation signals.

Authors:  Lauri L Binné; Martin L Scott; Paul D Rennert
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

3.  Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer.

Authors:  Ayna Alfadhli; Doug Huseby; Eliot Kapit; Dalbinder Colman; Eric Barklis
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

4.  Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.

Authors:  Akira Ono; Abdul A Waheed; Eric O Freed
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

5.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Identification of Tim4 as a phosphatidylserine receptor.

Authors:  Masanori Miyanishi; Kazutoshi Tada; Masato Koike; Yasuo Uchiyama; Toshio Kitamura; Shigekazu Nagata
Journal:  Nature       Date:  2007-10-24       Impact factor: 49.962

7.  Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.

Authors:  Akira Ono; Sherimay D Ablan; Stephen J Lockett; Kunio Nagashima; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

8.  T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface.

Authors:  Erhu Cao; Xingxing Zang; Udupi A Ramagopal; Arunika Mukhopadhaya; Alexander Fedorov; Elena Fedorov; Wendy D Zencheck; Jeffrey W Lary; James L Cole; Haiteng Deng; Hui Xiao; Teresa P Dilorenzo; James P Allison; Stanley G Nathenson; Steven C Almo
Journal:  Immunity       Date:  2007-03       Impact factor: 31.745

9.  TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

Authors:  Norimoto Kobayashi; Piia Karisola; Victor Peña-Cruz; David M Dorfman; Masahisa Jinushi; Sarah E Umetsu; Manish J Butte; Haruo Nagumo; Irene Chernova; Baogong Zhu; Arlene H Sharpe; Susumu Ito; Glenn Dranoff; Gerardo G Kaplan; Jose M Casasnovas; Dale T Umetsu; Rosemarie H Dekruyff; Gordon J Freeman
Journal:  Immunity       Date:  2007-12       Impact factor: 31.745

10.  Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family.

Authors:  César Santiago; Angela Ballesteros; Cecilia Tami; Laura Martínez-Muñoz; Gerardo G Kaplan; José M Casasnovas
Journal:  Immunity       Date:  2007-03       Impact factor: 31.745

View more
  41 in total

1.  TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.

Authors:  Minghua Li; Abdul A Waheed; Jingyou Yu; Cong Zeng; Hui-Yu Chen; Yi-Min Zheng; Amin Feizpour; Björn M Reinhard; Suryaram Gummuluru; Steven Lin; Eric O Freed; Shan-Lu Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-06       Impact factor: 11.205

2.  CD4-Dependent Modulation of HIV-1 Entry by LY6E.

Authors:  Jingyou Yu; Chen Liang; Shan-Lu Liu
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

3.  Cell-cell contact promotes Ebola virus GP-mediated infection.

Authors:  Chunhui Miao; Minghua Li; Yi-Min Zheng; Fredric S Cohen; Shan-Lu Liu
Journal:  Virology       Date:  2015-12-03       Impact factor: 3.616

4.  Differential binding of the HIV-1 envelope to phosphatidylserine receptors.

Authors:  Linlin Gu; Brian Sims; Alexandre Krendelchtchikov; Edlue Tabengwa; Qiana L Matthews
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-06-13       Impact factor: 3.747

Review 5.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

Review 6.  Multifaceted Roles of TIM-Family Proteins in Virus-Host Interactions.

Authors:  John P Evans; Shan-Lu Liu
Journal:  Trends Microbiol       Date:  2019-11-12       Impact factor: 17.079

7.  Exosomes Exploit the Virus Entry Machinery and Pathway To Transmit Alpha Interferon-Induced Antiviral Activity.

Authors:  Zhenlan Yao; Yunsheng Qiao; Xiaofang Li; Jieliang Chen; Jiahui Ding; Lu Bai; Fang Shen; Bisheng Shi; Jia Liu; Lu Peng; Jianhua Li; Zhenghong Yuan
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

8.  Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.

Authors:  Chen Cai; Yi-Fan Xu; Zhen-Jie Wu; Qin Dong; Min-Yu Li; Jason C Olson; Yaron M Rabinowitz; Lin-Hui Wang; Yinghao Sun
Journal:  World J Urol       Date:  2015-08-08       Impact factor: 4.226

9.  Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.

Authors:  Bettina P Iliopoulou; Katie Hsu; Magdiel Pérez-Cruz; Sai-Wen Tang; Wendy W Pang; Tom Erkers; Neeraja Kambham; Gordon J Freeman; Rosemarie H Dekruyff; Everett H Meyer
Journal:  Blood Adv       Date:  2019-11-12

10.  TIM-3, a Possible Target for Immunotherapy in Cancer and Chronic Viral Infections.

Authors:  Roger Tieu; Praveen Kumar Amancha; François Villinger; Siddappa N Byrareddy
Journal:  Austin Virol Retro Virol       Date:  2014-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.